SEARCH RESULTS

18365 RESULTS

New Partnership Forms to Harness AI for Alzheimer’s Research

CONFERENCE COVERAGE 2025-04-11 Conference Coverage As advanced biomedical technologies have allowed scientists to gather growing and increasingly complex datasets, even the most brilliant human minds grappling with the windfall can’t possibly keep up. Yawning gaps have spread out betwe

PrimeC

THERAPEUTICS NeuroSense Therapeutics Ciprofloxacin and Celecoxib Combination Inflammation Metals Other From November 2019 to January 2021, a one-year, open-label pilot trial in Israel enrolled 16 ALS patients. Participants took 909 mg celecoxib and ciprofloxacin daily

Zapping the Zoster Virus, Dodging Dementia

RESEARCH NEWS 2025-04-11 Research News Vaccination against shingles may come with a surprising perk. A recent study posits that the vaccine for herpes zoster, also known as shingles, protects against more than a painful, angry rash. According to real-world data, individuals who r

AD/PD™ 2025: Advances in Science & Therapy

CONFERENCE COVERAGE SERIES Finally, PET Tracers For α-Synuclein Yield Signal in Idiopathic Parkinson’s New Partnership Forms to Harness AI for Alzheimer’s Research Moving Target: New Biology Casts TREM2 as a Shifty Mark TREM2: A Chill Pill for Neurons? Trialists Grapple with How to

NUZ-001

THERAPEUTICS N-[(2S)-2-cyano-1-[5-cyano-2-(trifluoromethyl)phenoxy]propan-2-yl]-4-(trifluoromethylsulfanyl)benzamide Neurizon Therapeutics S-Monepantel Zolvix® Small Molecule Other A Phase 1 pilot in six cancer patients found 28 days of 5 mg/kg daily monepantel to hav

Current Filters

  • Date Range : Apr 2024 to Apr 2025 x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE